The FDA states very clearly: These compounded versions are not the same, he said
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: design and baseline characteristics of SOUL, a randomized trial
Medications that address multiple aspects of metabolic syndrome are increasingly being recognized as valuable
Due to their impact on both incretin systems, Dual GIP and GLP-1 agonists like tirzepatide (sold under brand names Mounjaro or Zepbound) are much more effective for weight loss
The trial, which was funded by the apitegromab producer Scholar Rock, revealed after 24 weeks that total weight loss was similar for the two groups
Poor sleep shifts the autonomic balance toward sympathetic dominance, which increases resting heart rate independently